These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 29853770)
1. Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes. Alves MRP; Boia R; Campos EJ; Martins J; Nunes S; Madeira MH; Santiago AR; Pereira FC; Reis F; Ambrósio AF; Baptista FI Mol Vis; 2018; 24():353-366. PubMed ID: 29853770 [TBL] [Abstract][Full Text] [Related]
2. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022 [TBL] [Abstract][Full Text] [Related]
4. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes. Li J; Wang P; Ying J; Chen Z; Yu S Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397 [TBL] [Abstract][Full Text] [Related]
5. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy. Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009 [TBL] [Abstract][Full Text] [Related]
6. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009 [TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Ouyang H; Mei X; Zhang T; Lu B; Ji L Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667 [TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death. Jia Y; Jiang S; Chen C; Lu G; Xie Y; Sun X; Huang L Mol Med Rep; 2019 Jun; 19(6):4863-4871. PubMed ID: 31059064 [TBL] [Abstract][Full Text] [Related]
9. Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats. Wang YL; Wang K; Yu SJ; Li Q; Li N; Lin PY; Li MM; Guo JY Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):389-98. PubMed ID: 25359392 [TBL] [Abstract][Full Text] [Related]
10. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Zheng L; Gong B; Hatala DA; Kern TS Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):361-7. PubMed ID: 17197555 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC Nitric Oxide; 2000 Dec; 4(6):590-6. PubMed ID: 11139367 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-9 (TLR-9) deficiency alleviates optic nerve injury (ONI) by inhibiting inflammatory response in vivo and in vitro. Zhang L; Li X Exp Cell Res; 2020 Nov; 396(1):112159. PubMed ID: 32652081 [TBL] [Abstract][Full Text] [Related]
14. Consumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes. Tzeng TF; Hong TY; Tzeng YC; Liou SS; Liu IM Nutrients; 2015 Sep; 7(9):7821-41. PubMed ID: 26389948 [TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481 [TBL] [Abstract][Full Text] [Related]
16. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967 [TBL] [Abstract][Full Text] [Related]
18. α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes. Zhang L; Dong L; Liu X; Jiang Y; Zhang L; Zhang X; Li X; Zhang Y PLoS One; 2014; 9(4):e93433. PubMed ID: 24695675 [TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats. Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045 [TBL] [Abstract][Full Text] [Related]